The atherogenic index of plasma (AIP) is the logarithm of the ratio of triglycerides to HDL cholesterol, both in mmol/L. It was proposed by Dobiášová and Frohlich as a simple marker of the atherogenic lipid profile. AIP correlates with the size of LDL and HDL particles and with the esterification rate of HDL cholesterol: higher values indicate a predominance of small, dense, more atherogenic LDL particles. It rises with obesity, insulin resistance, type 2 diabetes and metabolic syndrome.
AIP = log₁₀ [ TG (mmol/L) / HDL-C (mmol/L) ]
Example: triglycerides 1.5 mmol/L and HDL-C 1.3 mmol/L give TG/HDL-C = 1.15 and AIP = log₁₀ 1.15 ≈ 0.06. With TG 3.0 and HDL-C 0.9 mmol/L, the ratio is 3.3 and AIP ≈ 0.52. If values are in mg/dL, convert them first (TG ÷ 88.6, HDL-C ÷ 38.67). Otherwise the result will be shifted.
AIP combines two components of "atherogenic dyslipidaemia": high triglycerides and low HDL-C. In many observational studies higher AIP was associated with coronary artery disease, metabolic syndrome, fatty liver disease and obesity, and it predicted risk beyond LDL-C in some populations. AIP is not included as a treatment target in the European or American guidelines. It is an additional indicator that helps interpret the lipid profile, especially when LDL-C looks normal.
Abdominal obesity, insulin resistance, diabetes, excess sugar and alcohol, smoking, inactivity, hypothyroidism.
Weight loss, regular aerobic exercise, less sugar and refined carbohydrates, limiting alcohol, good glucose control; fibrates and omega-3 fatty acids lower triglycerides.
A high AIP is a reason to look at the whole metabolic picture: waist size, blood pressure, blood glucose and HbA1c, and liver tests. Discuss it with your doctor together with LDL-C and overall cardiovascular risk.
This article is for general information and does not replace a consultation with a doctor. Laboratory results must be interpreted by a physician together with symptoms and other tests.
Published on 18 April 2024